Shiro Nakayama

470 citations
8 papers · 329 indexed · h-index 5
Topics
Chronic Lymphocytic Leukemia Research (2 papers)Neonatal Health and Biochemistry (2 papers)Multiple Myeloma Research and Treatments (2 papers)
Partner nations
Japan

In The Last Decade

Shiro Nakayama

8 papers receiving 315 citations

Peers

Shiro Nakayama
Comparison fields: 5 of 42
  • Oncology 212
  • Hematology 195
  • Genetics 80
  • Emergency Medicine 46
  • Public Health, Environmental and Occupational Health 44
Replace A. M. Testi with:
A. M. Testi Italy
Junichi Miyatake Japan
Kohmei Kubo Japan
Dae-Chul Jeong South Korea
M. Rodet France
Stefano D’Ardìa Italy
Erika Biral Italy
Hidekazu Masuoka Japan
Marta Barrios Spain
José Falantes Spain
Shiro Nakayama relative to A. M. Testi Italy A. M. Testi's profile →
Citations per field
00.5×
A. M. Testi · 1×
Citations per year

Countries citing papers authored by Shiro Nakayama

Since Specialization
Citations

This map shows the geographic impact of Shiro Nakayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Nakayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Nakayama more than expected).

Fields of papers citing papers by Shiro Nakayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Nakayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Nakayama. The network helps show where Shiro Nakayama may publish in the future.

Co-authorship network of co-authors of Shiro Nakayama

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Nakayama. A scholar is included among the top collaborators of Shiro Nakayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Nakayama. Shiro Nakayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 4
2 9
3 281
4 15
5
[Anti-ATLA antibody positive T cell lymphoma arising from the nasopharynx--a case report].
1
6 11
7
[A case of no-anomaly type multiple myeloma with marked chromosomal abnormalities].
2
8
Chromosome Abnormality and Its Significance in Human Multiple Myeloma
6

About Shiro Nakayama

Shiro Nakayama is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 8 papers that have together received 329 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (2 papers), Neonatal Health and Biochemistry (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Hematology (195 citations), Oncology (212 citations) and Emergency Medicine (46 citations). Shiro Nakayama has collaborated with scholars based in Japan. Frequent co-authors include Akihisa Kanamaru, Mitsuhiro Omine, Akira Miura, Nobuyuki Hamajima, Yoshiyuki Niho, Masao Tomonaga, Tohru Kobayashi, Yutaka Yoshida, Ryuzo Ohno and Hakumei Oh. Their work appears in journals such as New England Journal of Medicine, Cancer and Human Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026